Allostery Investments LP Kal Vista Pharmaceuticals, Inc. Transaction History
Allostery Investments LP
- $95.7 Billion
- Q4 2024
A detailed history of Allostery Investments LP transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Allostery Investments LP holds 479,100 shares of KALV stock, worth $4.68 Million. This represents 4.24% of its overall portfolio holdings.
Number of Shares
479,100Holding current value
$4.68 Million% of portfolio
4.24%Shares
1 transactions
Others Institutions Holding KALV
# of Institutions
135Shares Held
52MCall Options Held
551KPut Options Held
98K-
Vr Adviser, LLC New York, NY6.25MShares$61 Million8.73% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.91MShares$48 Million1.73% of portfolio
-
Tang Capital Management LLC San Diego, CA4.89MShares$47.8 Million3.11% of portfolio
-
Vestal Point Capital, LP New York, NY4.77MShares$46.6 Million2.4% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.69MShares$36 Million2.3% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $240M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...